Skip to main content

News

The latest updates on company announcements, product news, and words from our leadership.

CaviWipes™ Added to EPA List N

Jul 12, 2021
This memo is to inform you that CaviWipes has been added to the EPA’s List N1 as of the date of this memo. The CDC’s Interim Infection Prevention and Control recommendation refers to the EPA’s List N that lists EPA-registered disinfectants products for use against SARS-CoV-22.

Metrex Disinfectant Update 5.13.2020

Jul 12, 2021
With testing protocols for disinfectant efficacy against SARS-CoV-2 recently approved and validated by the EPA and 3rd party testing labs, Metrex will be among the first to be testing our disinfectant product lines for efficacy against SARS-CoV-2 for submission to the EPA for approval.

COVID-19 Demand Memo

Jul 12, 2021
Due to the global urgent need at medical facilities driven by the outbreak of the COVID-19 pandemic, we are experiencing record demand during this time.

Coronavirus Disease 2019 (COVID-19) and Metrex Surface Disinfectants

Jul 12, 2021
As of the date of this writing, there is currently no EPA recognized test protocol to evaluate disinfection efficacy against this specific novel coronavirus virus strain, SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which causes COVID-19 (Coronavirus Disease 2019).

Facts about CaviWipes and SARS-COV-2 (novel coronavirus)

Jul 12, 2021
As of the date of this writing, there is currently no EPA recognized test protocol to evaluate disinfection efficacy against this specific novel coronavirus virus strain, SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which causes COVID-19 (Coronavirus Disease 2019).

2019 Novel Coronavirus Outbreak

Jul 12, 2021
This update is in response to the recent outbreak of the 2019 Novel Coronavirus or “2019-nCoV” by the U.S. Center of Disease Control (CDC), in Wuhan, China.